维普中文期刊产品整合服务

Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection

查看全文 作  者:Jingyun [1]Yang;Weiqi [1]Hong;Hong [1]Lei;Cai [1]He;Wenwen [2]Lei;Yanan [3]Zhou;Tingmei [1]Zhao;Aqu [1]Alu;Xuelei [1]Ma;Jiong [1]Li;Li [1]Yang;Zhenling [1]Wang;Wei [1]Wang;Guangwen [1]Lu;Guobo [1]Shen;Shuaiyao [3]Lu;Guizhen [2]Wu;Huashan [1]Shi;Xiawei [1]Wei 高影响力作者 机构地区:[1]Laboratory of Aging Research and Cancer Drug Target,Department of Biotherapy and Cancer Center,National Clinical Research Center for Geriatrics,West China Hospital,Sichuan University,No.17,Block 3,Southern Renmin Road,Chengdu,Sichuan 610041,People’s Republic of China;[2]NHC Key Laboratory of Biosafety,National Institute for Viral Disease Control and Prevention,Chinese Center for Disease Control and Prevention(China CDC),Beijing 102206,China;[3]National Kunming High-level Biosafety Primate Research Center,Institute of Medical Biology,Chinese Academy of Medical Sciences and Peking Union Medical College,Kunming,Yunnan,China高影响力机构 出  处:《Signal Transduction and Targeted Therapy》索引2023年第8卷第7期,共12页高影响力期刊 基  金:This work was supported by the National Science Foundation for Excellent Young Scholars(32122052);National Natural Science Foundation Regional Innovation and Development(No.U19A2003);National Natural Science Foundation of China(82200018).Figure 1a was created by BioRender. 摘  要:The COVID-19 response strategies in Chinese mainland were recently adjusted due to the reduced pathogenicity and enhanced infectivity of Omicron subvariants.In Chengdu,China,an infection wave was predominantly induced by the BA.5 subvariant.It is crucial to determine whether the hybrid anti-SARS-CoV-2 immunity following BA.5 infection. 关 键 词:IMMUNITY INFECTION ANTIBODIES
相关文献

参考文献(40)

引证文献(4)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费